346 related articles for article (PubMed ID: 12771608)
1. Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: incidence and risk factors.
Dünser MW; Mayr AJ; Tür A; Pajk W; Barbara F; Knotzer H; Ulmer H; Hasibeder WR
Crit Care Med; 2003 May; 31(5):1394-8. PubMed ID: 12771608
[TBL] [Abstract][Full Text] [Related]
2. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study.
Dünser MW; Mayr AJ; Ulmer H; Knotzer H; Sumann G; Pajk W; Friesenecker B; Hasibeder WR
Circulation; 2003 May; 107(18):2313-9. PubMed ID: 12732600
[TBL] [Abstract][Full Text] [Related]
3. [Arginine-vasopressin in septic and vasodilatorial shock].
Dünser MW; Hasibeder WR; Wenzel V; Meier-Hellmann A
Anasthesiol Intensivmed Notfallmed Schmerzther; 2006 Nov; 41(11):716-9. PubMed ID: 17151983
[TBL] [Abstract][Full Text] [Related]
4. Cardiac performance during vasopressin infusion in postcardiotomy shock.
Dünser MW; Mayr AJ; Stallinger A; Ulmer H; Ritsch N; Knotzer H; Pajk W; Mutz NJ; Hasibeder WR
Intensive Care Med; 2002 Jun; 28(6):746-51. PubMed ID: 12107681
[TBL] [Abstract][Full Text] [Related]
5. The vasopressin and copeptin response to infection, severe sepsis, and septic shock.
Jochberger S; Dörler J; Luckner G; Mayr VD; Wenzel V; Ulmer H; Morgenthaler NG; Hasibeder WR; Dünser MW
Crit Care Med; 2009 Feb; 37(2):476-82. PubMed ID: 19114902
[TBL] [Abstract][Full Text] [Related]
6. Effects of continuous vasopressin infusion in patients with septic shock.
Obritsch MD; Jung R; Fish DN; MacLaren R
Ann Pharmacother; 2004; 38(7-8):1117-22. PubMed ID: 15178740
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous vascular reactivity and flow motion response to vasopressin in advanced vasodilatory shock and severe postoperative multiple organ dysfunction syndrome.
Luckner G; Dünser MW; Stadlbauer KH; Mayr VD; Jochberger S; Wenzel V; Ulmer H; Pajk W; Hasibeder WR; Friesenecker B; Knotzer H
Crit Care; 2006; 10(2):R40. PubMed ID: 16542484
[TBL] [Abstract][Full Text] [Related]
8. [Arginine vasopressin in vasodilatory shock: a new therapy approach?].
Dünser M; Wenzel V; Mayr AJ; Hasibeder WR
Anaesthesist; 2002 Aug; 51(8):650-9; discussion 659-60. PubMed ID: 12391525
[TBL] [Abstract][Full Text] [Related]
9. Does arginine vasopressin influence the coagulation system in advanced vasodilatory shock with severe multiorgan dysfunction syndrome?
Dünser MW; Fries DR; Schobersberger W; Ulmer H; Wenzel V; Friesenecker B; Hasibeder WR; Mayr AJ
Anesth Analg; 2004 Jul; 99(1):201-206. PubMed ID: 15281530
[TBL] [Abstract][Full Text] [Related]
10. Effects of titrated arginine vasopressin on hemodynamic variables and oxygen transport in healthy and endotoxemic sheep.
Westphal M; Stubbe H; Sielenkämper AW; Ball C; Van Aken H; Borgulya R; Bone HG
Crit Care Med; 2003 May; 31(5):1502-8. PubMed ID: 12771625
[TBL] [Abstract][Full Text] [Related]
11. Lack of an effect of body mass on the hemodynamic response to arginine vasopressin during septic shock.
Lam SW; Bauer SR; Cha SS; Oyen LJ
Pharmacotherapy; 2008 May; 28(5):591-9. PubMed ID: 18447658
[TBL] [Abstract][Full Text] [Related]
12. Endocrinologic response to vasopressin infusion in advanced vasodilatory shock.
Dünser MW; Hasibeder WR; Wenzel V; Schwarz S; Ulmer H; Knotzer H; Pajk W; Friesenecker BE; Mayr AJ
Crit Care Med; 2004 Jun; 32(6):1266-71. PubMed ID: 15187504
[TBL] [Abstract][Full Text] [Related]
13. High-dose vasopressin is not superior to norepinephrine in septic shock.
Klinzing S; Simon M; Reinhart K; Bredle DL; Meier-Hellmann A
Crit Care Med; 2003 Nov; 31(11):2646-50. PubMed ID: 14605537
[TBL] [Abstract][Full Text] [Related]
14. Predictors of prolonged vasopressin infusion for the treatment of septic shock.
Personett HA; Stollings JL; Cha SS; Oyen LJ
J Crit Care; 2012 Jun; 27(3):318.e7-12. PubMed ID: 22227078
[TBL] [Abstract][Full Text] [Related]
15. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent.
Argenziano M; Chen JM; Choudhri AF; Cullinane S; Garfein E; Weinberg AD; Smith CR; Rose EA; Landry DW; Oz MC
J Thorac Cardiovasc Surg; 1998 Dec; 116(6):973-80. PubMed ID: 9832689
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR;
Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
[TBL] [Abstract][Full Text] [Related]
17. Intravenous arginine vasopressin infusion in refractory vasodilatory shock: a clinical study.
Agrawal A; Singh VK; Varma A; Sharma R
Indian J Pediatr; 2012 Apr; 79(4):488-93. PubMed ID: 21922300
[TBL] [Abstract][Full Text] [Related]
18. Vasopressin in sepsis and septic shock.
Kampmeier TG; Rehberg S; Westphal M; Lange M
Minerva Anestesiol; 2010 Oct; 76(10):844-50. PubMed ID: 20935620
[TBL] [Abstract][Full Text] [Related]
19. Discontinuation of vasopressin before norepinephrine increases the incidence of hypotension in patients recovering from septic shock: a retrospective cohort study.
Bauer SR; Aloi JJ; Ahrens CL; Yeh JY; Culver DA; Reddy AJ
J Crit Care; 2010 Jun; 25(2):362.e7-362.e11. PubMed ID: 19926252
[TBL] [Abstract][Full Text] [Related]
20. Transfusion of fresh frozen plasma in critically ill surgical patients is associated with an increased risk of infection.
Sarani B; Dunkman WJ; Dean L; Sonnad S; Rohrbach JI; Gracias VH
Crit Care Med; 2008 Apr; 36(4):1114-8. PubMed ID: 18379235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
